Chase Doyle

Multiplex gene testing may not bring about unnecessary surgery or adverse psychological effects, according to findings from a recent study.

An analysis of patients with advanced hepatocellular carcinoma and elevated AFP who received second-line Cyramza showed improved survival, according to data from the phase 3 REACH study.